trial

Smoking Cessation for Veterans With Severe and Persistent Mental Illness

NCTId NCT00960375
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase 2, Phase 3 · Completed
Enrollment 179 (actual)
Sponsored by US Department of Veterans Affairs
Primary completion 2014-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
Phase 2, Phase 3
Status
Completed
Enrollment
179 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2010-04
Primary completion
2014-03
Eligibility
ALL · 18 Years · 75 Years

Interventions & indications

Drugs
BTSCSStSST

Sponsors

US Department of Veterans AffairsLead Sponsor

Investigators

1
Melanie Bennett, PhDPrincipal Investigator

Sites

2 total
Washington D.C., United StatesBaltimore, United States

Linked catalysts

1
Smoking Cessation for Veterans With Severe and Persistent Mental Illness — primary completion2014-03

Facts & assertions

4 sourced
Enrollment
179
Phase
PHASE2,PHASE3
Primary Completion Date
2014-03
Status
COMPLETED
relationships
The graph out of here
drug
BTSCS
drug
StSST
drug
lead_sponsor
US Department of Veterans Affairs
company
indication
Affective Disorders, Psychotic
indication
Bipolar Disorder
indication
Schizoaffective Disorder
indication
investigator
Melanie Bennett, PhD
person